Many diagnosed with Type 2 diabetes may actually have a different form of the disease

[ad_1] When Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was handed pamphlets with information on two types of the disease.…

Glucose monitors are gaining popularity among those without diabetes

[ad_1] This stick-on arm patch is among the new generation of glucose monitors. ADVERTISEMENT UK resident Claire Reach doesn’t have diabetes but has been trialling various monitors for the past…

You Can Now Get Weight-Loss Drugs Right From Eli Lilly

[ad_1] Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound, an unusual move into the drug supply chain by…

Fake weight loss and diabetes drugs entering U.S. market

[ad_1] IE 11 is not supported. For an optimal experience visit our site on another browser. Maine becomes second state to rule Trump ineligible for 2024 primary ballot 00:42 Gypsy…

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

[ad_1] In pharma, you can take a larger slice of the healthcare pie than your peers, but you are still constrained by the size of the pie. No matter how…

Struggle with diabetes – A journalist’s story – Ghana Business News

[ad_1] A small itchy toenail robbed his peace in October 2014. Abrantie could only sub a few stories for the day and went home, with so much discomfort. As usual,…

Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln

[ad_1] Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire…

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the…

Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

[ad_1] Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for…

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care

[ad_1] ROCKVILLE, Md.and SUZHOU,China, Nov. 21, 2023 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of…